A Phase II Single-Blind Placebo-Controlled Sequential Treatment Multiple Ascending Dose Study to Evaluate the Safety and Tolerability of Donepezil with Solifenacin in Patients with Alzheimer's Disease Type Dementia
-
- STATUS
- Not Recruiting
Summary
The purpose of this study is to find out what the maximum tolerated dose (MTD) of donepezil when given with solifenacin and to evaluate the safety and tolerability of this combination, but the effects on signs and symptoms of Alzheimer?s disease will also be evaluated.
Description
The purpose of this study is to find out what the maximum tolerated dose (MTD) of donepezil when given with solifenacin and to evaluate the safety and tolerability of this combination, but the effects on signs and symptoms of Alzheimer?s disease will also be evaluated.
Details
| Condition | Alzheimer's Disease Type Dementia |
|---|---|
| Age | 50years - 79years |
| Clinical Study Identifier | TX4179 |
| Last Modified on | 19 February 2024 |
Similar trials to consider
Not finding what you're looking for?
Sign up as a volunteer to stay informed
Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.
Sign up as volunteerStudy Definition
WikipediaAdd a private note
- Select a piece of text.
- Add notes visible only to you.
- Send it to people through a passcode protected link.